Wall Street Braces for Fed Decision & Tech Earnings Storm
US markets face their most critical test of 2024 as Federal Reserve policy meeting and Big Tech earnings converge in a high-stakes week that could redefine market trajectory.
Category : Search result: pharma earnings
Q2 Results 2025: L&T, ITC, Indian Oil Earnings Next Week
Get ready for a blockbuster week as corporate giants including L&T, ITC, Indian Oil, Swiggy, and Adani Green prepare to announce Q2 FY2025 results, setting the tone for market direction.
Mukul Agrawal's ₹200 Cr Pharma Stock Bet Revealed
Discover why prominent investor Mukul Agrawal is betting big on a small-cap pharma company with massive growth potential. Get exclusive insights into his latest portfolio move and what it means for retail investors.
Dr. Reddy's Legacy: Transforming Indian Pharma
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.
YouTube Pays 3X More Than Films+TV: Parmeet Sethi
Exclusive: Veteran Bollywood actor Parmeet Sethi decodes the economics of YouTube vs traditional entertainment, revealing how vlogging provides lifelong premium earnings.
Bangladeshi generic drug slashes rare disease treatment cost by 96%
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
Sigachi Q2: Profit Halves, Revenue Down 19%
Sigachi Industries faces turbulent quarter with net profit crashing to ₹10.5 crore amid significant revenue decline. What's behind the pharmaceutical giant's disappointing performance?
Cipla Shares Fall 3% Despite Eli Lilly Weight Loss Drug Deal
Cipla's stock faces unexpected pressure despite securing rights to manufacture and distribute Eli Lilly's revolutionary weight loss drug Mounjaro in India. Discover why investors remain cautious.
Cipla-Eli Lilly deal brings weight loss drugs to India
Indian pharmaceutical giant Cipla announces landmark deal with Eli Lilly to manufacture and distribute popular weight loss medications Mounjaro and Zepbound in India under different brand names.
Aurobindo Pharma Expands to Chile with New Subsidiary
Indian pharma giant Aurobindo Pharma establishes new subsidiary in Chile, marking strategic expansion across South American markets with focus on branded prescriptions and over-the-counter medicines.
Torrent Pharma gets CCI nod for JB Chemicals stake
In a major pharmaceutical industry move, Torrent Pharmaceuticals receives Competition Commission of India approval to acquire controlling stake in JB Chemicals & Pharmaceuticals, marking significant consolidation in Indian pharma sector.
Indian Pharma Wins Crucial Legal Battle for Generic Drugs
A significant legal triumph for India's pharmaceutical sector strengthens the position of generic drug makers against patent challenges. Explore how this ruling impacts affordable medicine production and India's role as the 'Pharmacy of the World'.
Wall Street Flat: Tesla Earnings Watch, Netflix Plunges 8%
US stocks traded flat as investors await Tesla's crucial earnings report while Netflix shares tumble 8% following mixed quarterly results. Key market insights and analysis.
Netflix Shares Fall 6.5% After Q3 Earnings Miss
Netflix faces significant stock market pressure as Q3 earnings disappoint investors. Discover the key factors behind the 6.5% drop and what it means for the streaming giant's future.
Novo Nordisk Board Reshuffle: New Faces at the Helm
Danish pharma giant Novo Nordisk, the company behind diabetes & weight-loss blockbusters Ozempic and Wegovy, announces a major boardroom reshuffle. Get the inside scoop on the new faces and strategic direction.
Top 10 Self-Made Women Billionaires in Healthcare
Meet the trailblazing female entrepreneurs who built healthcare empires from scratch and are reshaping medical innovation worldwide. Discover their inspiring journeys to billions.
Nigerian Drug Cartels Recruit Indian Pharma Students: Delhi Police
Delhi Police uncovers how Nigerian drug cartels are recruiting Indian students from pharma colleges, providing specialized training, and creating sophisticated dispatch systems to smuggle narcotics globally.
Zydus vs Rubicon: Pharma Stock Analysis
Expert analysis compares Zydus Lifesciences and Rubicon Research in the booming Indian pharmaceutical sector. Discover key financial metrics, growth drivers, and investment outlook for these promising stocks.
Wall Street Awaits Earnings Tsunami Amid Trade Fears
As US-China tensions simmer and credit concerns linger, Wall Street turns to mega-cap earnings from Tesla, Meta, and Microsoft for market direction. Discover how global markets are reacting.
Indian Pharma Q2 Preview: Steady Growth Amid Challenges
India's pharmaceutical sector gears up for Q2 FY25 with projected 5-7% revenue growth, navigating US pricing pressures and domestic GST reductions while maintaining stable profitability.
Wall Street Soars on Earnings Optimism, Risk Appetite Returns
US stock markets staged a powerful rally as strong corporate earnings and cooling inflation fueled investor risk appetite. Discover which sectors led the charge and what's next for global markets.
India's Earnings Downgrade Cycle Ending: Kotak
Kotak Institutional Equities reports India's corporate earnings downgrade cycle is ending. Sanjeev Prasad highlights improving fundamentals, FPI interest, and economic growth drivers set to boost India Inc performance.
NCB busts high-tech drug lab in Ratlam, arrests pharma grads
In a major breakthrough, Narcotics Control Bureau uncovers sophisticated drug manufacturing unit in Madhya Pradesh's Ratlam district. Highly educated pharma graduates among those arrested in interstate narcotics operation.
India Mandates QR Codes on All Essential Medicines
India mandates safety QR codes on all essential medicines in public healthcare, transforming drug safety and combating counterfeit drugs with digital innovation.
Q2 Earnings: HUL, SBI Life Among 40+ Stocks Reporting
Get ready for a blockbuster week as corporate India's Q2 earnings season hits high gear. Hindustan Unilever, SBI Life Insurance, and over 40 other companies set to unveil their financial performance, offering crucial insights into market direction and eco
Luka Dončić Net Worth 2025: Lakers Star's Wealth
Discover how Luka Dončić built his staggering net worth in 2025. From NBA contracts to endorsements, explore the financial journey of the Los Angeles Lakers superstar.
MP SIT to Make More Arrests in Pharma Tragedy
Madhya Pradesh's Special Investigation Team gears up for significant arrests in the Sresan Pharma cough syrup case that claimed young lives. Exclusive details on the expanding investigation.
Q2 Results: HDFC Bank, ICICI, Yes Bank, PNB Earnings Today
Major Indian banking and cement stocks including HDFC Bank, ICICI Bank, Yes Bank, PNB, Ultratech Cement and UTI Asset Management to announce Q2 FY24 results today. Get expert analysis on what to expect from these key players.
Supreme Court allows generic SMA drug in blow to Roche
In a landmark judgment, India's Supreme Court allows Natco Pharma to produce affordable generic version of Roche's expensive spinal muscular atrophy treatment, making life-saving therapy accessible to thousands.
Reliance Q2 Profit Surges 16%, Jio & Retail Excel
Mukesh Ambani's Reliance Industries reports stellar Q2 results with 16% profit surge, fueled by robust performance in Jio and retail sectors. Discover how India's largest conglomerate continues its growth trajectory.
Page 4 of 4